Venclexta (venetoclax) - Roche, AbbVie
CCTx-001 - Advesya
https://ash.confex.com/ash/2024/webprogram/Paper199673.html
 
Mohamad Sabbah, MD1; Morgane Fontaine2; Kim Pacchiardi3; Alexis Delabrière4; Stephane De Botton, MD, PhD5; Catherine Lonchamp2; Renaud Buffet, MD6; Laure Farnault, MD7; Jean-Baptiste Micol, MD8; Typhaine Dumas-Rivero, PharmD9; Emmanuel Raffoux, MD10,11; Lionel Ades, MD, PhD1; Nicolas Boissel, MD, PhD12; Juliette Lambert, MD, PhD13; Kevin-James Wattebled, MD14; Matthieu Duchmann, MD, PhD15; Karine Celli-Lebras, RN16,17; Alexandra Coelho18; Hervé Dombret, MD, PhD19; Edouard De Dreuzy, PhD20; Marina Deschamps, PhD21,22; Christophe Ferrand, PhD22,23; Jens Hasskarl, MD, PhD24; Richard Sainson20; Raphael Itzykson25,26,27
 
Nov 6, 2024
 
Prev Next